1. Home
  2. SNTI vs TBHC Comparison

SNTI vs TBHC Comparison

Compare SNTI & TBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • TBHC
  • Stock Information
  • Founded
  • SNTI 2016
  • TBHC 1966
  • Country
  • SNTI United States
  • TBHC United States
  • Employees
  • SNTI N/A
  • TBHC N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • TBHC Other Specialty Stores
  • Sector
  • SNTI Health Care
  • TBHC Consumer Discretionary
  • Exchange
  • SNTI Nasdaq
  • TBHC Nasdaq
  • Market Cap
  • SNTI 39.6M
  • TBHC 32.3M
  • IPO Year
  • SNTI N/A
  • TBHC N/A
  • Fundamental
  • Price
  • SNTI $1.56
  • TBHC $1.57
  • Analyst Decision
  • SNTI Strong Buy
  • TBHC
  • Analyst Count
  • SNTI 2
  • TBHC 0
  • Target Price
  • SNTI $8.50
  • TBHC N/A
  • AVG Volume (30 Days)
  • SNTI 107.2K
  • TBHC 183.6K
  • Earning Date
  • SNTI 08-07-2025
  • TBHC 09-16-2025
  • Dividend Yield
  • SNTI N/A
  • TBHC N/A
  • EPS Growth
  • SNTI N/A
  • TBHC N/A
  • EPS
  • SNTI N/A
  • TBHC N/A
  • Revenue
  • SNTI N/A
  • TBHC $431,111,000.00
  • Revenue This Year
  • SNTI N/A
  • TBHC N/A
  • Revenue Next Year
  • SNTI $150.00
  • TBHC N/A
  • P/E Ratio
  • SNTI N/A
  • TBHC N/A
  • Revenue Growth
  • SNTI N/A
  • TBHC N/A
  • 52 Week Low
  • SNTI $1.46
  • TBHC $1.20
  • 52 Week High
  • SNTI $16.94
  • TBHC $1.73
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 37.24
  • TBHC N/A
  • Support Level
  • SNTI $1.52
  • TBHC N/A
  • Resistance Level
  • SNTI $1.65
  • TBHC N/A
  • Average True Range (ATR)
  • SNTI 0.10
  • TBHC 0.00
  • MACD
  • SNTI 0.03
  • TBHC 0.00
  • Stochastic Oscillator
  • SNTI 50.00
  • TBHC 0.00

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About TBHC The Brand House Collective Inc. Common Stock

The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

Share on Social Networks: